NCT00974350 - A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Postoperative PainHerniaSurgery

Interventions

DRUG

SABER-Bupivacaine

Injectable Extended Release Solution; 2.5 mL SABER-Bupivacaine/Once

DRUG

SABER-Bupivacaine

Injectable Extended Release Solution; 5.0 mL SABER-Bupivacaine/Once

DRUG

SABER-Placebo

Injectable Solution; 2.5 or 5.0 mL SABER-Placebo/Once

Trial Locations (5)

Ringwood East

Sunnybank

Cairns

Port Lincoln

Hamilton